Oh Sang Woo, Shin Soon-Ae, Yun Young Ho, Yoo Taiwoo, Huh Bong-Yul
Department of Family Medicine and Center for Health Promotion, Ilsan-paik Hospital, College of Medicine, Inje University, Goyang, South Korea.
Obes Res. 2004 Dec;12(12):2031-40. doi: 10.1038/oby.2004.254.
The need for a lower BMI to classify overweight in Asian populations has been controversial. Using both disease and mortality outcomes, we investigated whether lower BMI cut-off points are appropriate for identifying increased health risk in Koreans.
We conducted a cohort study among 773,915 men and women from 30 to 59 years old with 8- to 10-year follow-up periods. Primary outcomes were change of obesity prevalence, obesity-related disease incidence, and all-cause mortality.
Prevalence of overweight (BMI of 25.0-29.9) has steadily increased (1.3% annually), whereas obesity (BMI > or = 30) showed a lower prevalence and only a slight increase (0.1%-0.2% annually). Our study revealed that dose-response relationships exist between obesity and related disease incidences (hypertension, type 2 diabetes, and hypercholesterolemia) beginning at lower BMI levels than previously reported. Compared with those in the healthy weight range, Koreans with a BMI > or = 25 were not at greater risk of hypertension, type 2 diabetes, or hypercholesterolemia than has been reported for whites in similar studies. Obesity-related all-cause mortality also did not seem so different from that of whites.
Our findings did not support the use of a lower BMI cut-off point for defining overweight in Koreans compared with whites for the purpose of identifying different risks. However, populations with BMI > or = 25 are rapidly increasing and have substantial risks of diseases. To preempt the rapid increases in obesity and related health problems that are occurring in Western countries, Korea should consider using a BMI of 25 as an action point for obesity prevention and control interventions.
在亚洲人群中,采用较低的体重指数(BMI)来界定超重一直存在争议。我们通过疾病和死亡率这两个指标,研究了较低的BMI切点是否适用于识别韩国人健康风险的增加。
我们对773915名年龄在30至59岁之间的男性和女性进行了队列研究,随访期为8至10年。主要结局指标为肥胖患病率的变化、肥胖相关疾病的发病率以及全因死亡率。
超重(BMI为25.0至29.9)的患病率稳步上升(每年1.3%),而肥胖(BMI≥30)的患病率较低且仅略有上升(每年0.1%至0.2%)。我们的研究表明,肥胖与相关疾病(高血压、2型糖尿病和高胆固醇血症)的发病率之间存在剂量反应关系,且起始BMI水平低于先前报道。与体重处于健康范围的人群相比,BMI≥25的韩国人患高血压、2型糖尿病或高胆固醇血症的风险并不高于类似研究中报道的白人。肥胖相关的全因死亡率与白人相比似乎也没有太大差异。
我们的研究结果不支持为了识别不同风险,与白人相比采用较低的BMI切点来界定韩国人的超重情况。然而,BMI≥25的人群正在迅速增加,且有患疾病的重大风险。为了预防西方国家正在出现的肥胖及相关健康问题的快速增长,韩国应考虑将BMI为25作为肥胖预防和控制干预的行动切点。